Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease
Clinical trial NCT04271163 · UNKNOWN
Trial details
- NCT number
- NCT04271163
- Sponsor
- NeuroEM Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2021-02-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.